This erratum corrects the following:
Madeleine R. Heldman, Olivia S. Kates, Kassem Safa, et al. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: a comparative analysis from a multicenter study. Am J Transplant. 2021;21(8):2774–2784. https://doi.org/10.1111/ajt.16692
In the originally published version of this article, values are missing in Table 2. The corrected version of Table 2 is presented below.
TABLE 2.
Outcomes among hospitalized solid organ transplant recipients with Covid-19 (lung vs. non-lung)
| Lung (n=117) | Non-lung (n=934) | p-value | |
| Death by 28 daysa | 28 (24.0) | 151 (16.2) | 0.035* |
| ICU admission | 52 (44.4) | 346 (37.0) | 0.12 |
| Mechanical ventilation | 33 (28.2) | 250 (26.8) | 0.74 |
| Extracorporeal membrane oxygenation | 3 (3.1) | 10 (1.3) | 0.17 |
| Acute kidney injuryb | 40 (34.2) | 378 (40.5) | 0.19 |
| Bacterial pneumoniac | 12 (10.3) | 70 (7.5) | 0.29 |
| Fungal pneumoniad | 3 (2.6) | 4 (0.4) | 0.01* |
| Bloodstream infectione | 2 (1.7) | 50 (5.4) | 0.09 |
| Acute cellular rejection | 2 (1.7) | 9 (1.0) | 0.45 |
25/28 (89%) of deaths among lung recipients and 127/151 (84%) deaths among non-lung recipients occurred in patients admitted to an ICU. 19/28 (67%) of deaths among lung recipients and 114/151 (75%) deaths among non-lung recipients occurred in patients who were mechanically ventilated.
Acute kidney injury defined as >50% increase in creatinine from baseline.
Includes cases in which a pathogen was isolated on respiratory culture; excludes empirically treated cases. Respiratory bacterial pathogens in lung recipients included Pseudomonas spp. (n = 10), Klebsiella spp. (n = 1), E. coli (n = 1), Stenotrophomonas maltophilia (n = 1). Pathogens in non-lung recipients included Pseudomonas (n = 23), Klebsiella spp. (n = 11), E. coli (n = 7), Stenotrophomonas maltophila (n = 4), Burkholderia spp. (n = 5), Citrobacter spp. (n = 3), Enterobacter spp. (n = 2), Acinetobacter spp. (n = 2), Proteus spp. (n = 1), Achromobacter spp. (n = 1), Hafnia spp. (n = 1), Staphylococcus aureus (n = 24), and Streptococcus spp. Some patients had more than one pathogen isolated.
Includes cases in which a pathogen was identified; excludes diagnoses based on galactomannan or imaging findings alone. Aspergillus was isolated in 2 lung recipients and 3 non-lung recipients. One non-lung recipient had Rhizopus and one non-lung recipient had Cryptococcus.
Bloodstream pathogens in lung recipients included Stenotrophomonas maltophila (n = 1) and Enterococcus spp. (n = 1). Bloodstream pathogens in non-lung recipients included Pseudomonas spp. (n = 7), E. coli (n = 10), Enterobacter spp. (n = 1), Stenotrophomonas maltophila (n = 1), Proteus spp. (n-1), Staphylococcus aureus (n = 21), Streptococcus spp. (n = 1), Enterococcus spp. (=8), and Candida spp. (n = 6). Excludes possible contaminants: coagulase-negative staphylococcus (0 lung, 17 non-lung recipients) Bacillus spp (1 non-lung recipient), and Corynebacterium spp (1 non-lung recipient).
Denotes statistically significant at α ≤ 0.05.
We regret the error.
REFERENCES
- 1.Heldman MR, Kates OS, Safa K, et al. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: a comparative analysis from a multicenter study. Am J Transplant. 2021;21(8):2774–2784. doi: 10.1111/ajt.16692. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]